Product Information
MARAVIROC 300 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $7.0607 per EA under NDC 31722058060. Its NADAC has been published 115 times since Apr 17, 2024.
Strength
300 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722058060
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MARAVIROCApproval Type
Generic (ANDA)
FDA Application
ANDA203347On Market Since
2/6/2022
Pharmacological Classes
Price Statistics
The NADAC for MARAVIROC 300 MG TABLET has been published 115 times since Apr 17, 2024, and over the history we have for it it has declined 65.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.0607 per EA |
|---|---|
| All-time high | $20.8330 (Jun 12, 2024) |
| All-time low | $7.0607 (Jun 17, 2026) |
| 52-week high | $19.5337 |
| 52-week low | $7.0607 |
| Median price | $16.7694 |
| Average price | $15.4422 |
| Largest weekly change | -22.9% (Sep 17, 2025) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MARAVIROC 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MARAVIROC 300 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $7.0607 per EA (NDC 31722058060), effective Jun 24, 2026.
How has the price of MARAVIROC 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for MARAVIROC 300 MG TABLET has declined 65.8%. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for MARAVIROC 300 MG TABLET?
Since Apr 17, 2024, the NADAC for MARAVIROC 300 MG TABLET has ranged from a low of $7.0607 (Jun 17, 2026) to a high of $20.8330 (Jun 12, 2024), with a median of $16.7694 per EA.
Are there cheaper alternatives to MARAVIROC 300 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as MARAVIROC 300 MG TABLET, but none are currently priced below it.
Who manufactures MARAVIROC 300 MG TABLET?
MARAVIROC 300 MG TABLET (NDC 31722058060) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification